Pma/510k: reported device not marketed in the u.S., however, similar devices or devices that share components, raw materials, process methods or other technological characteristics are registered within the u.S.K133890.Investigation: analysis and results: there are no previous complaints of this code-batch.We manufactured and distributed in the market 828 units of this code-batch.There are no units in our stock.We have received 16 closed samples and 1 open sample with a piece of thread broken.We have checked the thread surface appearance of the closed samples received and is the correct and usual one.Sewing test on artificial skin tissue has been conducted with the closed samples received and fraying/splitting does not appear when pulling the thread through the tissue.Visual appearance is the usual one after performing this test.We have also tested the knot pull tensile strength of the closed samples received and the results fulfill the requirements of the european pharmacopoeia (ep): 0.37 kgf in average and 0.29 kgf in minimum (ep requirements: 0.15 kgf in average and 0.06 kgf in minimum).Additionally, needle attachment strength test has been conducted on the closed samples received in order to discard a faulty needle-attachment during manufacturing process, but the results fulfill the requirements of the european pharmacopoeia (ep): 0.29 kgf in average and 0.218 kgf in minimum (ep requirements: 0.17 kgf in average and 0.082 kgf in minimum).We have not found splitting on thread surface on the closed samples received before and after performing tests.Reviewed the batch manufacturing record, this product had a normal process and the results during the process fulfil usp/ep and b.Braun surgical requirements.Knot pull tensile strength results before releasing the product were 0.40 kgf in average and 0.37 kgf in minimum and fulfilled ep requirements.Remarks: when working with optilene® suture material, great care should be taken to avoid any crushing or crimping damage of the monofilament by instruments such as forceps or needle holders.Final conclusion: although the results of the closed samples received fulfil the specifications of european pharmacopoeia/ b.Braun surgical specifications, we take note of this incidence in order to assess if new or additional actions are needed.Actions on product distributed of this reference/batch: based on the conclusion derived from investigation, it is not required to make actions in distributed product.No corrective/preventive actions needed.
|